This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
Provenge has not been approved by the FDA. The current hooha has arisen because of press releases put out by the manufacturers who say that when the results of the recently completed trials are published the FDA will approve the drug.
Maybe they will; maybe they won't. Certainly the price of the stock has rocketed.
One of the "guesstimates" of the cost is that is that it is going to be more than $65,000 for a course of treatment, if it is approved.
